From February 23, 2024 to March 31, 2024, the company has repurchased 1,958,445 shares, representing 0.46% for CNY 27.58 million. With this, the company has completed the repurchase of 1,958,445 shares, representing 0.46% for CNY 27.58 million under the buyback announced on February 24, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.24 CNY | +2.45% | +2.74% | -5.88% |
05-15 | China Grants Drug Registration for Huiyu Pharma's Two Injectables | MT |
04-26 | Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-5.88% | 833M | |
+40.73% | 739B | |
+30.93% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.77% | 240B | |
+9.18% | 210B | |
-5.36% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 688553 Stock
- News Sichuan Huiyu Pharmaceutical Co., Ltd.
- Tranche Update on Sichuan Huiyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.